Oramed Pharmaceuticals (ORMP) SEC Filings & 10K Form

$2.30
0.00 (0.00%)
(As of 11:16 AM ET)

Recent Oramed Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/09/2024
4:00 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
8:00 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2024
7:07 PM
Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:30 PM
Oramed Pharmaceuticals (Issuer)
Reznick Yehuda (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2024
8:30 PM
KIDRON NADAV (Filed by)
Oramed Pharmaceuticals (Subject)
Form SC 13D
03/19/2024
7:00 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
4:15 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:00 PM
Oramed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
7:42 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
7:42 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
4:30 PM
Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
3:45 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:45 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:36 PM
Oramed Pharmaceuticals (Issuer)
Rozov Yadin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:37 PM
Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:39 PM
Oramed Pharmaceuticals (Issuer)
Silberman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:40 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:41 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:43 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:32 PM
Oramed Pharmaceuticals (Issuer)
Shapiro Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:33 PM
Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:34 PM
Mayer Arie (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
12:13 PM
Aghion Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/21/2023
8:26 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2023
3:45 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
4:10 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/26/2023
3:34 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2023
7:47 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2023
7:30 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
8:20 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
4:10 PM
Oramed Pharmaceuticals (Issuer)
Silberman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
4:10 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
4:10 PM
Derovan Netanel (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
4:10 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
4:10 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
4:20 PM
Oramed Pharmaceuticals (Filer)
Form DEF 14A
05/31/2023
4:21 PM
Oramed Pharmaceuticals (Filer)
Form ARS
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ORMP) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners